NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

ViiV Healthcare gets FDA approval for injectable HIV treatment Cabenuva

By NS Healthcare Staff Writer 22 Jan 2021

ViiV Healthcare said that Cabenuva is the first and only complete long-acting regimen for the treatment of HIV-1 infection in adults

Boston Scientific to acquire cardiac health solutions provider....

The acquisition of Preventice will provide Boston Scientific with a foothold in

Merck secures US FDA approval for Verquvo to....

Merck claimed that its Verquvo is the first soluble guanylate cyclase stimulator

AstraZeneca, Daiichi Sankyo’s Enhertu approved for breast cancer....

EC approval is based on results from Phase 2 DESTINY-Breast01 trial, which

Lilly, Merus collaborate on T-Cell re-directing bispecific antibody....

The research and license collaboration aims to research and develop up to

Pharmaceuticals

AstraZeneca, Daiichi Sankyo’s Enhertu approved for gastric cancer in US
19 Jan 21

Innovent out-licenses Byvasda rights to Etana in Indonesia
19 Jan 21

Thermo Fisher acquires Novasep’s viral vector manufacturing business
18 Jan 21

Patient Care

ViiV Healthcare gets FDA approval for injectable HIV treatment Cabenuva

Boston Scientific to acquire cardiac health solutions provider....

Merck secures US FDA approval for Verquvo to....

AstraZeneca, Daiichi Sankyo’s Enhertu approved for breast cancer....

Lilly, Merus collaborate on T-Cell re-directing bispecific antibody....

Pharmaceuticals

AstraZeneca, Daiichi Sankyo’s Enhertu approved for gastric cancer in US
19 Jan 21

Innovent out-licenses Byvasda rights to Etana in Indonesia
19 Jan 21

Thermo Fisher acquires Novasep’s viral vector manufacturing business
18 Jan 21

Patient Care

Thermo Fisher to buy molecular diagnostics firm Mesa Biotech for $450m
20 Jan 21

Medtronic commences first aDBS trial in Parkinson’s disease patients
15 Jan 21

Pfizer invests $120m in four clinical-stage biotech firms under PBGI
13 Jan 21

Nutraceuticals

Abbott expands Pedialyte product line with four new formulations
15 Dec 20

Abbott introduces first infant formula similar to breast milk in Canada
18 Nov 20

SGC gets FDA IND approval for gummy-based allergy medication
16 Oct 20

NS Healthcare is using cookies

AstraZeneca, Daiichi Sankyo’s Enhertu approved for gastric cancer in US19 Jan 21

Innovent out-licenses Byvasda rights to Etana in Indonesia19 Jan 21

Thermo Fisher acquires Novasep’s viral vector manufacturing business18 Jan 21

Thermo Fisher to buy molecular diagnostics firm Mesa Biotech for $450m 20 Jan 21

Medtronic commences first aDBS trial in Parkinson’s disease patients 15 Jan 21

Pfizer invests $120m in four clinical-stage biotech firms under PBGI 13 Jan 21

Abbott expands Pedialyte product line with four new formulations15 Dec 20

Abbott introduces first infant formula similar to breast milk in Canada18 Nov 20

SGC gets FDA IND approval for gummy-based allergy medication16 Oct 20

OUR TITLES

Lilly invests $30m in new capital....18 Jan 21

Taking connected healthcare to ‘the next....15 Jun 20

UK needs better PPE stockpiles for....12 Jun 20

Fujifilm to invest $928m to expand....10 Jun 20

Merck acquires mRNA-based contract manufacturer AmpTec08 Jan 21

Hologic to acquire molecular diagnostics firm....06 Jan 21

Servier to acquire Agios Pharmaceuticals’ oncology....22 Dec 20

Philips to buy medical technology firm....21 Dec 20

Vir-GSK partnership to begin AGILE study....13 Jan 21

Novartis collaborates with BeiGene for cancer....12 Jan 21

Pfizer, BioNTech sign $1.9bn deal for....24 Dec 20

Pfizer, PostEra partner to advance machine....08 Dec 20

AstraZeneca, Daiichi Sankyo’s Enhertu approved for gastric cancer in US
19 Jan 21

Innovent out-licenses Byvasda rights to Etana in Indonesia
19 Jan 21

Thermo Fisher acquires Novasep’s viral vector manufacturing business
18 Jan 21

Thermo Fisher to buy molecular diagnostics firm Mesa Biotech for $450m
20 Jan 21

Medtronic commences first aDBS trial in Parkinson’s disease patients
15 Jan 21

Pfizer invests $120m in four clinical-stage biotech firms under PBGI
13 Jan 21

Abbott expands Pedialyte product line with four new formulations
15 Dec 20

Abbott introduces first infant formula similar to breast milk in Canada
18 Nov 20

SGC gets FDA IND approval for gummy-based allergy medication
16 Oct 20

Lilly invests $30m in new capital....
18 Jan 21

Taking connected healthcare to ‘the next....
15 Jun 20

UK needs better PPE stockpiles for....
12 Jun 20

Fujifilm to invest $928m to expand....
10 Jun 20

Merck acquires mRNA-based contract manufacturer AmpTec
08 Jan 21

Hologic to acquire molecular diagnostics firm....
06 Jan 21

Servier to acquire Agios Pharmaceuticals’ oncology....
22 Dec 20

Philips to buy medical technology firm....
21 Dec 20

Vir-GSK partnership to begin AGILE study....
13 Jan 21

Novartis collaborates with BeiGene for cancer....
12 Jan 21

Pfizer, BioNTech sign $1.9bn deal for....
24 Dec 20

Pfizer, PostEra partner to advance machine....
08 Dec 20